Mouwasat Medical Services Co.’s net profit rose marginally to SAR 473.9 million in the first nine months of 2024, from SAR 473.5 million a year earlier.
Item | 9m 2023 | 9m 2024 | Change |
---|---|---|---|
Revenues | 1,932.45 | 2,123.83 | 9.9 % |
Gross Income | 919.68 | 971.19 | 5.6 % |
Operating Income | 547.66 | 539.26 | (1.5 %) |
Net Income | 473.52 | 473.92 | 0.1 % |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 2.37 | 2.37 | 0.1 % |
This was supported by an increase in the number of outpatient and inpatient visits. This is in addition the improvement in some contractual terms with the company's customers.
The company also cited the ongoing strong performance of the specialized departments at its hospitals, along with continued enhancement of operating efficiency of the available resources.
Moreover, the nine-month period witnessed a year-on-year (YoY) revenue growth, amid lower financing costs as the company narrowed its loan balance by settling some installments during this period.
In Q3 2024, net profit fell 4% to SAR 149.6 million, compared with SAR 156.38 million a year ago, mainly due to the continued increase in debt provisions related to customer balances, which put pressure on the profit margins for the current quarter and for the first nine months of this year.
Net earnings also dropped 2% from SAR 152.70 million in Q2 2024, although revenues climbed by 3% on a quarterly basis.
Item | Q3 2023 | Q3 2024 | Change |
---|---|---|---|
Revenues | 640.89 | 710.74 | 10.9 % |
Gross Income | 298.26 | 317.93 | 6.6 % |
Operating Income | 182.40 | 167.78 | (8.0 %) |
Net Income | 156.38 | 149.64 | (4.3 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.78 | 0.75 | (4.3 %) |
Item | Q2 2024 | Q3 2024 | Change |
---|---|---|---|
Revenues | 690.30 | 710.74 | 3.0 % |
Gross Income | 307.43 | 317.93 | 3.4 % |
Operating Income | 176.20 | 167.78 | (4.8 %) |
Net Income | 152.70 | 149.64 | (2.0 %) |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.76 | 0.75 | (2.0 %) |
Shareholders’ equity, after minority interest, rose to SAR 3.40 billion as of Sept. 30, 2024, from SAR 3.09 billion in the year-ago period.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}